A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
Clinical trial NCT06581575 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06581575
- Sponsor
- Immorna Biotherapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-16
- Primary completion
- 2026-08-01
- Enrollment
- 467
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.